Anti-tumor effect in an in vivo model by human-derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic properties
-
- YAGI Hiroshi
- Department of Surgery, Keio University School of Medicine
-
- UEDA Masakazu
- Department of Surgery, Keio University School of Medicine
-
- JINNO Hiromitsu
- Department of Surgery, Keio University School of Medicine
-
- AIURA Koichi
- Department of Surgery, Keio University School of Medicine
-
- MIKAMI Shuji
- Department of Pathology, Keio University School of Medicine
-
- TADA Hiroko
- Department of Bioscience and Biotechnology, Faculty of Engineering, Graduate School of Natural Science and Technology, Okayama University
-
- SENO Masaharu
- Department of Bioscience and Biotechnology, Faculty of Engineering, Graduate School of Natural Science and Technology, Okayama University
-
- YAMADA Hidenori
- Department of Bioscience and Biotechnology, Faculty of Engineering, Graduate School of Natural Science and Technology, Okayama University
-
- KITAJIMA Masaki
- Department of Surgery, Keio University School of Medicine
この論文をさがす
収録刊行物
-
- Cancer science
-
Cancer science 97 (12), 1315-1320, 2006-12-10
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1572824500399694336
-
- NII論文ID
- 10020387699
-
- NII書誌ID
- AA11808050
-
- ISSN
- 13479032
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles